贝伐单抗
伊立替康
医学
胶质母细胞瘤
内科学
肿瘤科
外科
化疗
癌症
结直肠癌
癌症研究
作者
Henry S. Friedman,Michael D. Prados,Patrick Y. Wen,Tom Mikkelsen,David Schiff,Lauren E. Abrey,W.K. Alfred Yung,Nina A. Paleologos,M. Kelly Nicholas,Randy L. Jensen,James J. Vredenburgh,Jane Huang,Maoxia Zheng,Timothy F. Cloughesy
标识
DOI:10.1200/jco.2008.19.8721
摘要
Bevacizumab, alone or in combination with irinotecan, was well tolerated and active in recurrent glioblastoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI